Financials

  • Market Capitalization 660.29 M
  • Employee 808
  • Founded 2006
  • CEO Timothy R Wright
  • Website www.mimedx.com
  • Headquarter Georgia, United States
  • FIGI BBG000RJ6FL5
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
96.25
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2710
SLN
Silence Therapeutics Plc - American Depository Share
14.73 USD+8.87%+7.75%+39.89%+200.61%695.94 M USD
2712
ALLO
Allogene Therapeutics, Inc. - Common Stock
1.99 USD-0.50%-8.29%+5.85%+77.68%687.53 M USD
2730
PRME
Prime Medicine, Inc. - Common Stock
3.58 USD-0.28%-3.50%+23.88%+12.93%649.33 M USD
2731
SGMT
Sagimet Biosciences Inc. - Series A Common Stock
10.52 USD+2.53%+2.24%+56.08%+41.97%653.91 M USD

Noticias